Investor Relations

News Release

February 8, 2019

Chemiphar to acquire marketing authorization for oral intestinal cleansing agent PICOPREP® In Japan (pdf, 148KB)

January 31, 2019

Chemiphar announced Third Quarter Business Summary FY2018. (pdf, 339KB)

January 23, 2019

Notice Regarding On-Site Inspection by the Japan Fair Trade Commission (pdf, 117KB)

January 16, 2019

Transfer of Marketing Authorization for Oral Intestinal Cleansing Agent PICOPREP® in Japan (pdf, 178KB)

December 13, 2018

Nippon Chemiphar Vietnam Factory Launches Exports to Japan (pdf, 275KB)

November 28, 2018

Chemiphar underwrites third party allocation of shares by AI drug discovery venture MOLCURE, commence negotiations toward business alliance.(pdf, 104KB)

November 9, 2018

Chemiphar announced Highlights of Second Quarter FY2018 Business Results (pdf, 417KB)

October 31, 2018

Notice of differences between forecasts and actual results for the 1st half FY2018. (pdf, 33KB)

October 31, 2018

Chemiphar announced Second Quarter Business Summary FY2018. (pdf, 340KB)

August 27, 2018

Corporate Report 2018 (Annual Report FY2017) (pdf, 5.2 MB)

July 31, 2018

Chemiphar announced First Quarter Business Summary FY2018. (pdf, 340KB)

June 8, 2018

Chemiphar announced Highlights of FY2017 Business Results (pdf, 1MB)

May 11, 2018

Chemiphar announced Business Summary FY2017 (pdf, 985KB)

January 31, 2018

Chemiphar announced Third Quarter Business Summary FY2017. (pdf, 543KB)

January 11, 2018

Cyclic Innovation for Clinical Empowerment (CiCLE) Adopts NC-2800 as an Antidepressant / Anxiolytic Drug Candidate. (pdf, 172KB)

Related Information
PageTop